WebThe human recombinant Interferon-alpha(2a) (IFNalpha(2a)) is a potent drug (Roferon-A) to treat various types of cancer and viral diseases including Hepatitis B/C infections. To improve the pharmacological properties of the drug, a new pegylated form of IFNalpha(2a) was developed (PEGASYS). Web2 mrt. 2024 · Interferon-alpha (rIFNα) is the only disease-modifying treatment for polycythemia vera (PV), but whether or not it prolongs survival is unknown. This large single center retrospective study of ...
Peginterferon α in the treatment of chronic hepatitis B - PubMed
WebHuman Interferon-alpha 2a produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 165 amino acids and having a molecular mass of 19241 Dalton. The Interferon-a 2a gene was obtained from human leukocytes. The rHuIFN-a 2a is purified by proprietary chromatographic techniques. 仅用于科研。 不用于诊断过程。 未经明确授权 … WebRecombinant Human IFNA-2A (Catalog # 10984-IF) demonstrates anti-viral activity in HeLa human cervical epithelial carcinoma cells infected with encephalomyocarditis (EMC) … the colour 9
Peginterferon Alfa-2a Injection: MedlinePlus Drug Information
WebRecombinant Human Interferon Alpha A (Alpha 2a) obtained from human leukocyte mRNA expressed in E.coli. IFN-Alpha 2a is one of the many interferon alpha subtypes … Web干擾素屬於 醣蛋白 。 目前在人類身上共發現α、β、γ三種類型:α型干擾素 (IFN-α)是由 白细胞 產生的;β型干擾素 (IFN-β)是由 成纖维细胞 (纖維母細胞)產生的; γ型干擾素 是 (IFN-γ)由 免疫系统 中的 T细胞 和 自然殺手細胞 產生的。 這三種都是有效的病毒抑制劑,並具有調節 免疫 的作用。 與一般抗病毒藥物不同的是干擾素是宿主特異的。 同一個 屬 [來源 … WebMETHODS: The study included 542 patients treated with PEG-IFN-alfa-2a (180 mu g/wk, 48 wk) and 266 patients treated with PEG-IFN-alfa-2b (100 mu g/wk, 52 wk). Eighty-seven patients were excluded, leaving 721 patients for analysis. A sustained response was defined as HBeAg loss and HBV-DNA level less than 2.0 X 10(3) IU/mL 6 months after treatment. the colour ash